Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision tag, Revision: v3.3.2, appears, replacing Revision: v3.2.0; this change is limited to metadata and does not affect the study content, eligibility criteria, or posted results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoval of the government funding lapse notice that instructed users to consult cc.nih.gov and opm.gov for operating-status updates. The page now shows the standard study details without the extra maintenance banner.SummaryDifference0.4%

- Check33 days agoChange DetectedVisual/UI updates to the study page with no changes to core study content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

- Check69 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check83 days agoChange DetectedVersion bump to v3.0.2 and removal of the 'Back to Top' link; no substantive content changes.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.